08.01.2019 • NewsAdamaElaine Burridge

Adama in Talks to Take China’s Anpon

Adama in Talks to Take China’s Anpon (c) Adama
Adama in Talks to Take China’s Anpon (c) Adama

Israeli crop protection producer Adama, a subsidiary of ChemChina, has disclosed that it is making “significant progress” towards acquiring China’s Jiangsu Anpon Electrochemical.

Also a wholly owned subsidiary of ChemChina, Anpon is a fully backward-integrated manufacturer of key active ingredients used in crop protection markets worldwide, notably ethephon, pymetrozine and buprofezin, as well as other intermediates such as chloralkali. It posted sales of around $234 million in 2017.

Adama said Anpon is fast becoming a key part of its global operations, adding synthesis and formulation capabilities to its operations in China. Anpon’s site in Huai’An City, Jiangsu province, is located next to Adama’s new global formulation facility. The Israeli producer added that work at its R&D center in Nanjing, China, is also resulting in major process improvements in Anpon’s production processes.

Both companies have reached an initial understanding and are now working towards signing a definitive purchase agreement, which will remain subject to corporate and regulatory approvals along with the usual closing conditions.  They have not given a timescale for the proposed transaction or any financial details.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.